Company · CIK 1628587

# Teva Pharmaceutical Finance Netherlands II B.V.

| CIK | [1628587](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001628587) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Business address | Netherlands |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-284770-03 | Shelf Effective | 2025-02-07 | 2026-09-11 | 5 |
| 333-260519-03 | Shelf Effective | 2021-10-27 | 2023-03-03 | 4 |
| 333-222767-01 | Shelf Dormant | 2018-01-29 | 2018-01-29 | 1 |

## Filings

 11

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1628587/000119312526389382/0001193125-26-389382-index.htm) Shelf takedown | 333-284770-03 | 0001193125-26-389382 |
| 2026-09-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1628587/000119312526386121/0001193125-26-386121-index.htm) Shelf takedown | 333-284770-03 | 0001193125-26-386121 |
| 2025-05-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1628587/000119312525125044/0001193125-25-125044-index.htm) Shelf takedown | 333-284770-03 | 0001193125-25-125044 |
| 2025-05-19 | [424B5](https://www.sec.gov/Archives/edgar/data/1628587/000119312525122087/0001193125-25-122087-index.htm) Shelf takedown | 333-284770-03 | 0001193125-25-122087 |
| 2025-02-07 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1628587/000119312525022747/0001193125-25-022747-index.htm) Shelf registered | 333-284770-03 | 0001193125-25-022747 |
| 2023-03-03 | [424B5](https://www.sec.gov/Archives/edgar/data/1628587/000119312523058961/0001193125-23-058961-index.htm) Shelf takedown | 333-260519-03 | 0001193125-23-058961 |
| 2023-02-27 | [424B5](https://www.sec.gov/Archives/edgar/data/1628587/000119312523049644/0001193125-23-049644-index.htm) Shelf takedown | 333-260519-03 | 0001193125-23-049644 |
| 2021-11-04 | [424B5](https://www.sec.gov/Archives/edgar/data/1628587/000119312521320227/0001193125-21-320227-index.htm) Shelf takedown | 333-260519-03 | 0001193125-21-320227 |
| 2021-10-27 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1628587/000119312521308706/0001193125-21-308706-index.htm) Shelf registered | 333-260519-03 | 0001193125-21-308706 |
| 2020-08-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1628587/999999999520002171/9999999995-20-002171-index.htm) Declared effective | 333-241010-01 | 9999999995-20-002171 |
| 2018-01-29 | [S-3](https://www.sec.gov/Archives/edgar/data/1628587/000119312518023821/0001193125-18-023821-index.htm) Shelf registered | 333-222767-01 | 0001193125-18-023821 |

[All filings of this company](https://equitycapital.markets/filings?cik=1628587) · [CSV](https://equitycapital.markets/filings.csv?cik=1628587)

---
Source page: https://equitycapital.markets/company/1628587 · Data: U.S. SEC EDGAR · CC BY 4.0